COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. It operates through the Active Ingredient and Biopharmaceutical segments. The Active Ingredient segment is involved in the development of proprietary extraction technologies. The Biopharmaceutical segment includes commercializing and developing pharmaceutical therapeutics and diagnostic tests. The company was founded on September 12, 1990 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. COSCIENS Biopharma Inc. market cap is $5.59M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. COSCIENS Biopharma Inc. 52 week high is $9.57 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. COSCIENS Biopharma Inc. 52 week low is $2.37 as of November 21, 2026.
COSCIENS Biopharma Inc. stock price today is $5.61.
COSCIENS Biopharma Inc. stock price yesterday was $5.79.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. COSCIENS Biopharma Inc.'s P/E ratio is -0.9.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. COSCIENS Biopharma Inc. P/B ratio is 0.5178.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. COSCIENS Biopharma Inc. 50-day moving average is $6.06.